These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30602586)

  • 1. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism.
    Arguedas-Ramírez G
    CRISPR J; 2020 Apr; 3(2):83-88. PubMed ID: 32315224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 4. Upstream Ethical Mapping of Germline Genome Editing.
    Halpern J; Paolo D
    Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
    [No Abstract]   [Full Text] [Related]  

  • 5. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
    Locke LG
    CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Council of Europe should not reaffirm the ban on germline genome editing in humans.
    Sykora P; Caplan A
    EMBO Rep; 2017 Nov; 18(11):1871-1872. PubMed ID: 28986351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.
    Guttinger S
    Sci Eng Ethics; 2018 Aug; 24(4):1077-1096. PubMed ID: 28653169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A society-wide conversation is needed about germline genome editing using CRISPR.
    Birney E
    Nat Med; 2024 Jan; 30(1):30-32. PubMed ID: 38177854
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR -Cas9: a groundbreaking new technique which ushers in new prospects and just as many doubts.
    Napoletano S; Piersanti V; Rallo G
    Clin Ter; 2021; 171(1):e52-e54. PubMed ID: 33346327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Editing 2020: Ethics and Human Rights in Germline Editing in Humans and Gene Drives in Mosquitoes.
    Annas GJ
    Am J Law Med; 2020 May; 46(2-3):143-165. PubMed ID: 32659189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
    Meyer M
    EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining CRISPR-based genome and epigenome editing off-targets.
    Luo Y
    Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
    [No Abstract]   [Full Text] [Related]  

  • 19. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year.
    Barrangou R
    CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.